NTRB
NASDAQ · Pharmaceuticals
Nutriband Inc
$6.90
+0.14 (+2.07%)
Financial Highlights (FY 2026)
Revenue
2.23M
Net Income
-8,993,791
Gross Margin
27.8%
Profit Margin
-404.1%
Rev Growth
-0.7%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 27.8% | 27.8% | 54.8% | 54.8% |
| Operating Margin | -408.4% | -367.6% | 14.3% | 15.1% |
| Profit Margin | -404.1% | -383.9% | 12.0% | 11.5% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 2.23M | 2.24M | 21.69M | 16.36M |
| Gross Profit | 619.1K | 623.4K | 11.89M | 8.96M |
| Operating Income | -9,091,966 | -8,239,622 | 3.11M | 2.47M |
| Net Income | -8,993,791 | -8,150,651 | 2.61M | 1.89M |
| Gross Margin | 27.8% | 27.8% | 54.8% | 54.8% |
| Operating Margin | -408.4% | -367.6% | 14.3% | 15.1% |
| Profit Margin | -404.1% | -383.9% | 12.0% | 11.5% |
| Rev Growth | -0.7% | -0.7% | +19.5% | +23.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.12M | 1.12M | 24.66M | 23.39M |
| Total Equity | 45.37M | 45.37M | 37.36M | 36.10M |
| D/E Ratio | 0.02 | 0.02 | 0.66 | 0.65 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -8,878,030 | -8,492,728 | 4.63M | 3.66M |
| Free Cash Flow | — | — | 2.95M | 1.96M |